Pipelinepharma now hosts 85.000+ CTD dossiers for finished-dosage-formulation pharmaceutical products. Over the course of 2021, the number of hosted products quadrupled (19.639 at the start of 2021, compared to 85.000 today).
“While quantity is sometimes a quality in itself, the product information on Pipelinepharma is expert-curated. It is essential to have relevant, rich and up-to-date CTD information, as any discrepancies would invalidate the deal from the very beginning”, - notes company CEO Mindaugas Zagorskis.
On Pipelinepharma every product features rich card data including GMP approvals, country of origin, dossier type, dossier status, stability data and many more. The platform also features a powerful search engine, enabling users to filter the products by any of aforementioned criteria, helping to discover relevant medicines in a few clicks.
Pipelinepharma curators also perform buyer, seller and deal qualification, leaving end-users with only relevant prospects.